Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 18, 2022

SELL
$20.04 - $23.84 $196,532 - $233,798
-9,807 Closed
0 $0
Q3 2021

Nov 22, 2021

SELL
$17.38 - $21.54 $7,421 - $9,197
-427 Reduced 4.17%
9,807 $198,000
Q2 2021

Aug 26, 2021

SELL
$18.47 - $22.11 $3,509 - $4,200
-190 Reduced 1.82%
10,234 $194,000
Q1 2021

Apr 28, 2021

BUY
$19.22 - $24.3 $200,349 - $253,303
10,424 New
10,424 $200,000

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.